GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, today reported that studies involving its knee and shoulder joint replacement innovations and its ExactechGPS® guided personalized surgery system were featured at the 29th Congress of The International Society for Technology in Arthroplasty (ISTA) in Boston, Massachusetts.
The studies presented by orthopaedic surgeons and Exactech engineers and scientists included a presentation, “Benefit of Modern Navigation System in Total Knee Arthroplasty" by Jung-Dong Chang, MD, PhD, who was honored as an ISTA Invited Faculty member from South Korea. His study of 272 total knee replacement surgeries using the Optetrak Logic® knee system, supported by the ExactechGPS computer-assisted surgery system, demonstrated accurate and reproducible results in terms of joint implant alignment and implant position.
Additional studies featuring Exactech technologies include the following:
Impact of Radiolucent Glenoid Lines on Clinical Outcomes in Anatomic
Total Shoulder Arthroplasty
Christopher Roche; Alexander Greene; Thomas Wright, MD; Pierre Henri Flurin, MD; Joseph Zuckerman, MD; Sean Grey, MD
Impact of Radiolucent Humeral Lines on aTSA Clinical Outcomes for
Cemented and Noncemented Humeral Stems
Christopher Roche; Alexander Greene; Pierre Henri Flurin, MD; Thomas Wright, MD; Joseph Zuckerman, MD; Richard Jones, MD
Rate of Improvement in Clinical Outcomes with Anatomic and Reverse
Total Shoulder Arthroplasty
Christopher Roche; Alexander Greene; Pierre Henri Flurin, MD; Thomas Wright, MD; Joseph Zuckerman, MD; Ryan Simovitch, MD
A Comparison of Clinical Outcomes With Anatomic and Reverse Total
Shoulder Arthroplasty at Midterm Followup
Christopher Roche; Alexander Greene; Pierre Henri Flurin, MD; Thomas Wright, MD; Joseph Zuckerman, MD
Knee Technologies & Surgical Techniques
Benefit of Modern Navigation System in Total Knee Arthroplasty
presented by ISTA invited faculty member Jun-Dong Chang, MD, PhD
Impact of the Tibial Alignment Method on Accuracy of Resection
Planning During TKA
Laurent Angibaud; Yifei Dai; Matthew Rueff; Michael B. Cross, MD; Kyle Swanson, MD; Matthew Crozier, MD; Brendan Williams, MD; Amaury Jung
Passive Reception of Feedback Does Not Improve the Accuracy of
Resection Planning During TKA
Yifei Dai; Laurent Angibaud; Matthew Rueff; Michael B.Cross, MD; Kyle Swanson, MD; Matthew Crozier, MD; Brendan Williams, MD; Amaury Jung
Impact of Experience on the Execution of Tibial Resection Planning
Matthew Rueff; Laurent Angibaud; Yifei Dai; Michael B. Cross, MD; Kyle Swanson, MD; Matthew Crozier, MD; Brendan Williams, MD, MD; Amaury Jung
Total Knee Arthroplasty Using a Contemporary Computer-Assisted
Surgical System: A Review of Surgical Parameters on More Than 4000
Yifei Dai; Fabrice Bertrand; Laurent Angibaud; Cyril Hamad; Amaury Jung; David Liu, MD; James Huddleston, MD; Bernard Stulberg, MD
Novel CT Based Cadaveric Validation of the Accuracy of a Computer
Navigated Surgery System
Alexander Greene; Matthew Hamilton; Sandrine Polakovic; Richard Andrews; Richard Jones, MD; Ira Parsons, MD; Paul Saadi,MD; Emilie Cheung, MD; Pierre Henri Flurin, MD; Thomas Wright, MD
Geographic Variations in the Surgical Profiles of Computer-Assisted
Total Knee Arthroplasty
Yifei Dai; Laurent Angibaud; Amaury Jung; Cyril Hamad; Fabrice Bertrand; James Huddleston, MD; Bernard Stulberg, MD
Computer-Assisted Total Knee Arthroplasty: Impact of Surgeon
Experience on the Ability to Achieve Surgical Resection Goals
Yifei Dai; Laurent Angibaud; Amaury Jung; Cyril Hamad; Fabrice Bertrand; Bernard Stulberg, MD; James Huddleston, MD
The International Society for Technology in Arthroplasty (ISTA) is a nonprofit corporation whose goal is to promote public awareness, education and research, in arthroplasty. The means by which this purpose is achieved is through ISTA’s Annual Congress where emerging technologies are discussed between surgeons, engineers, and industry.
Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech can be found at http://www.exac.com.
This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.